Board Meeting held on 14th February, 2026 to consider and approve standalone and consolidated unaudited financial results for the quarter ended December 31, 2025 along with limited review ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hipolin Ltd's board approved its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025 on February 14, 2026, with an unmodified limited review report from statutory auditor SDP M & Co. Revenue from operations fell sharply to Rs. 376.12 lakhs in Q3 FY26 from Rs. 503.73 lakhs in the same quarter last year, a decline of about 25%. For the nine-month period, revenue dropped to Rs. 1,020.77 lakhs from Rs. 1,716.12 lakhs, a steep fall of roughly 40% year-on-year. The company swung to a small standalone net profit of Rs. 0.84 lakhs in Q3 FY26 from a loss of Rs. 56.85 lakhs in Q3 FY25, though on a nine-month basis it remains in the red with a loss of Rs. 76.82 lakhs (vs. Rs. 91.31 lakhs loss a year ago). The full year FY25 had posted a loss of Rs. 327.70 lakhs. Consolidated figures are broadly similar, including results of subsidiary Jayantilal Bhogilal Chemicals Pvt Ltd. The company operates in a single segment – manufacturing of detergent powder and cake.
Mixed picture for shareholders – the quarterly turnaround into profit is encouraging, but the sharp year-on-year revenue contraction and persistent nine-month losses signal continued business stress which could weigh on the stock. The clean auditor review with no qualifications is a small positive, but absence of full-year recovery keeps risk elevated.